Abstract:Graphene is one of the most studied materials ever, owing to its exceptional electronic, mechanical and thermal properties, which allow for many different types of application. In this review, we shall concentrate on the use of graphene and derivatives for electrochemical sensors and biosensors, where emphasis is placed on the importance of surface functionalization as this permits synergistic combinations with other nanomaterials and biomolecules. In addition to describing recent advances in graphene‐based el… Show more
“…The latter is a common biomarker in a range of clinical conditions, such as hypertension [22], kidney function [23], stroke [24] and cardiovascular disease [25,26]. It is little surprise therefore that there is an extensive literature base on its electrochemical detection and, with continuing advances in 2D carbon nanomaterials and other catalytic particles, continues to hold the interest of the diagnostics [27][28][29][30][31]. While the present investigation has sought to examine the material characteristics of the composite MN array, the response to urate within horse blood, as a model system, was critically assessed along with its potential translation to transdermal applications.…”
Conductive microneedle patches consisting of carbon nanoparticles embedded in a polystyrene matrix have been prepared using micro-moulding techniques. The interfacial properties of the structures before and after electrochemical etching have been characterised using X-ray photoelectron spectroscopy and contact angle. Anodisation of the needles leads to a significant increase in oxygen functionality and is shown to dramatically improve the electroanalytical capabilities of the microneedle array. The detection of uric acid in horse blood was used as a model system through which to assess the performance of the system. The composite approach is shown to lead to viable carbon-based sensors and can offer a rapid prototype option for the development of tailored microneedle systems.
“…The latter is a common biomarker in a range of clinical conditions, such as hypertension [22], kidney function [23], stroke [24] and cardiovascular disease [25,26]. It is little surprise therefore that there is an extensive literature base on its electrochemical detection and, with continuing advances in 2D carbon nanomaterials and other catalytic particles, continues to hold the interest of the diagnostics [27][28][29][30][31]. While the present investigation has sought to examine the material characteristics of the composite MN array, the response to urate within horse blood, as a model system, was critically assessed along with its potential translation to transdermal applications.…”
Conductive microneedle patches consisting of carbon nanoparticles embedded in a polystyrene matrix have been prepared using micro-moulding techniques. The interfacial properties of the structures before and after electrochemical etching have been characterised using X-ray photoelectron spectroscopy and contact angle. Anodisation of the needles leads to a significant increase in oxygen functionality and is shown to dramatically improve the electroanalytical capabilities of the microneedle array. The detection of uric acid in horse blood was used as a model system through which to assess the performance of the system. The composite approach is shown to lead to viable carbon-based sensors and can offer a rapid prototype option for the development of tailored microneedle systems.
“…Reproduced with permission. [179] Copyright 2018, Wiley-VCH. b) The surface can be functionalized with a variety of different biomolecular recognition elements.…”
Nanostructured materials can now be engineered with great precision and complexity as a result of advances in design and fabrication, and offer distinct advantages in many biosensing and biomedical applications. The materials most widely used in this field are semiconductors and noble metals. Each offers multiple length scales of nanostructuring that program their physicochemical properties for different biosensing applications. Here, nanostructured materials and their applications are reviewed together with semiconductors and noble metals, as well as hybrid materials that unite these two classes—all with the goal of linking performance characteristics to applications in biomedicine.
“…These sensors can respond to specific chemical or biological compounds and convert this information into electrical signals. Many materials have been studied as the sensitive materials in the chemical/biological sensors, such as SnO 2 [ 1 , 2 ], ZnO 2 [ 3 ], Ag [ 4 ], and graphene [ 5 ]. Generally speaking, the ideal material in chemical and biological sensors should have a high chemical reactivity, a large surface to volume ratio or an easy fabrication at low cost.…”
Chemical and biological sensors have attracted great interest due to their importance in applications of healthcare, food quality monitoring, environmental monitoring, etc. Carbon nanotube (CNT)-based field-effect transistors (FETs) are novel sensing device configurations and are very promising for their potential to drive many technological advancements in this field due to the extraordinary electrical properties of CNTs. This review focuses on the implementation of CNT-based FETs (CNTFETs) in chemical and biological sensors. It begins with the introduction of properties, and surface functionalization of CNTs for sensing. Then, configurations and sensing mechanisms for CNT FETs are introduced. Next, recent progresses of CNTFET-based chemical sensors, and biological sensors are summarized. Finally, we end the review with an overview about the current application status and the remaining challenges for the CNTFET-based chemical and biological sensors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.